BAL PHARMA
Back to Cashflow Statement
|
BAL PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹20 Cr | ₹23 Cr | ₹-1.54 Cr | ₹27 Cr | ₹22 Cr |
What is the latest Cash Flow from Operating Activities ratio of BAL PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹20 Cr |
| Mar2024 | ₹23 Cr |
| Mar2023 | ₹-1.54 Cr |
| Mar2022 | ₹27 Cr |
| Mar2021 | ₹22 Cr |
How is Cash Flow from Operating Activities of BAL PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹20 Cr | -10.92 | |
| Mar2024 | ₹23 Cr | Positive | |
| Mar2023 | ₹-1.54 Cr | Negative | |
| Mar2022 | ₹27 Cr | 19.97 | |
| Mar2021 | ₹22 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹120.2 Cr | -0.8% | 14.8% | -28.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -0.8% |
14.8% |
-28.9% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses